110 related articles for article (PubMed ID: 8607145)
1. A physiologically based pharmacokinetic model for arsenic exposure. I. Development in hamsters and rabbits.
Mann S; Droz PO; Vahter M
Toxicol Appl Pharmacol; 1996 Mar; 137(1):8-22. PubMed ID: 8607145
[TBL] [Abstract][Full Text] [Related]
2. A physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans.
Mann S; Droz PO; Vahter M
Toxicol Appl Pharmacol; 1996 Oct; 140(2):471-86. PubMed ID: 8887465
[TBL] [Abstract][Full Text] [Related]
3. A physiologically based pharmacokinetic model of inorganic arsenic.
Yu D
Regul Toxicol Pharmacol; 1999 Apr; 29(2 Pt 1):128-41. PubMed ID: 10341143
[TBL] [Abstract][Full Text] [Related]
4. Arsenic metabolism and thioarsenicals in hamsters and rats.
Naranmandura H; Suzuki N; Iwata K; Hirano S; Suzuki KT
Chem Res Toxicol; 2007 Apr; 20(4):616-24. PubMed ID: 17381137
[TBL] [Abstract][Full Text] [Related]
5. Physiologically based modeling of 2-butoxyethanol disposition in rats following different routes of exposure.
Shyr LJ; Sabourin PJ; Medinsky MA; Birnbaum LS; Henderson RF
Environ Res; 1993 Nov; 63(2):202-18. PubMed ID: 8243415
[TBL] [Abstract][Full Text] [Related]
6. Use of in vitro data for construction of a physiologically based pharmacokinetic model for naphthalene in rats and mice to probe species differences.
Quick DJ; Shuler ML
Biotechnol Prog; 1999; 15(3):540-55. PubMed ID: 10356275
[TBL] [Abstract][Full Text] [Related]
7. A physiologically based pharmacokinetic (PB/PK) model for multiple exposure routes of soman in multiple species.
Sweeney RE; Langenberg JP; Maxwell DM
Arch Toxicol; 2006 Nov; 80(11):719-31. PubMed ID: 16718492
[TBL] [Abstract][Full Text] [Related]
8. PBPK models in risk assessment--A focus on chloroprene.
DeWoskin RS
Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
[TBL] [Abstract][Full Text] [Related]
9. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57BL6 mice following subchronic exposure to arsenate in drinking water.
Kenyon EM; Hughes MF; Adair BM; Highfill JH; Crecelius EA; Clewell HJ; Yager JW
Toxicol Appl Pharmacol; 2008 Nov; 232(3):448-55. PubMed ID: 18706920
[TBL] [Abstract][Full Text] [Related]
10. Comparison of tissue dosimetry in the mouse following chronic exposure to arsenic compounds.
Gentry PR; Covington TR; Lawrence G; McDonald T; Snow ET; Germolec D; Moser G; Yager JW; Clewell HJ
J Toxicol Environ Health A; 2005 Mar; 68(5):329-51. PubMed ID: 15799626
[TBL] [Abstract][Full Text] [Related]
11. Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to rats.
Suzuki KT; Katagiri A; Sakuma Y; Ogra Y; Ohmichi M
Toxicol Appl Pharmacol; 2004 Aug; 198(3):336-44. PubMed ID: 15276413
[TBL] [Abstract][Full Text] [Related]
12. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol.
Fisher JW; Mahle D; Abbas R
Toxicol Appl Pharmacol; 1998 Oct; 152(2):339-59. PubMed ID: 9853003
[TBL] [Abstract][Full Text] [Related]
13. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice.
Abbas R; Fisher JW
Toxicol Appl Pharmacol; 1997 Nov; 147(1):15-30. PubMed ID: 9356303
[TBL] [Abstract][Full Text] [Related]
14. Tissue distribution and urinary excretion of dimethylated arsenic and its metabolites in dimethylarsinic acid- or arsenate-treated rats.
Adair BM; Moore T; Conklin SD; Creed JT; Wolf DC; Thomas DJ
Toxicol Appl Pharmacol; 2007 Jul; 222(2):235-42. PubMed ID: 17559899
[TBL] [Abstract][Full Text] [Related]
15. Tissue distribution of arsenic species in rabbits after single and multiple parenteral administration of arsenic trioxide: tissue accumulation and the reversibility after washout are tissue-selective.
Lin CJ; Wu MH; Hsueh YM; Sun SS; Cheng AL
Cancer Chemother Pharmacol; 2005 Feb; 55(2):170-8. PubMed ID: 15322825
[TBL] [Abstract][Full Text] [Related]
16. Physiologically based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice.
Greenberg MS; Burton GA; Fisher JW
Toxicol Appl Pharmacol; 1999 Feb; 154(3):264-78. PubMed ID: 9931286
[TBL] [Abstract][Full Text] [Related]
17. A physiologically based pharmacokinetic description of the oral uptake, tissue dosimetry, and rates of metabolism of bromodichloromethane in the male rat.
Lilly PD; Andersen ME; Ross TM; Pegram RA
Toxicol Appl Pharmacol; 1998 Jun; 150(2):205-17. PubMed ID: 9653052
[TBL] [Abstract][Full Text] [Related]
18. Metabolism and excretion of gallium arsenide and arsenic oxides by hamsters following intratracheal instillation.
Rosner MH; Carter DE
Fundam Appl Toxicol; 1987 Nov; 9(4):730-7. PubMed ID: 3692028
[TBL] [Abstract][Full Text] [Related]
19. Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: a progress report.
Clewell HJ; Thomas RS; Gentry PR; Crump KS; Kenyon EM; El-Masri HA; Yager JW
Toxicol Appl Pharmacol; 2007 Aug; 222(3):388-98. PubMed ID: 17499324
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and excretion of orally and intraperitoneally administered gallium arsenide in the hamster.
Yamauchi H; Takahashi K; Yamamura Y
Toxicology; 1986 Sep; 40(3):237-46. PubMed ID: 3750324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
